Pharmaceuticals
Healthcare
Elder Pharma to focus on anti-infectives and explore new therapeutic areas after divesting formulations unit
Elder Pharmaceuticals Ltd, which is selling its domestic formulation business to Torrent Pharmaceuticals Ltd, will focus on its anti-infectives unit, ......
Healthcare
Biocon's marketing head Rakesh Bamzai resigns
Bangalore-based biotechnology company Biocon Ltd's president (marketing) Rakesh Bamzai has quit the firm, as per a company disclosure.Bamzai started his ......
Healthcare
Bain Capital buying out Blackstone's stake in Emcure Pharmaceuticals
PE major Blackstone is selling its equity stake in Pune-based pharmaceutical major Emcure Pharmaceuticals Ltd to Bain Capital for an ......
Healthcare
AstraZeneca to buy Bristol-Myers Squibb's stake in diabetes JV for up to $4.1B
AstraZeneca Plc, a global bio pharmaceutical company, has announced an agreement to acquire entire stake of Bristol-Myers Squibb Co (BMS) ......
Healthcare
Wockhardt raises $13.4M through IPO of European arm
Mumbai-based generic drugmaker Wockhardt Ltd has raised CHF 11.86 million ($13.37 million) in an initial public offering (IPO) through its ......
Healthcare
Glaxo makes $1B open offer to raise stake in Indian pharma arm
Global drug maker GlaxoSmithKline Plc (GSK) has made a voluntary open offer to raise its holding in its Indian pharma ......
Healthcare
OrbiMed-backed Shasun Pharma to sell Visakhapatnam plant
Mid-sized pharmaceutical firm Shasun Pharmaceuticals Ltd is looking to sell its unit situated at JN Pharma City in Visakhapatnam in Andhra Pradesh ......
Healthcare
CX Partners cuts deal size with Natco Pharma, now investing $18M
Private equity firm CX Partners has revised its proposed deal with Hyderabad-based Natco Pharma, bringing its investment down by 30 ......
Healthcare
Vyome Biosciences announces clinical trial results for first product
Delhi-based Vyome Biosciences Pvt Ltd, a biopharma firm which makes pharmaceutical and consumer care products for skin conditions, announced clinical ......
Healthcare
KKR investing $200M in Gland Pharma, Evolvence to exit
Private equity major KKR is picking up a minority stake in Gland Pharma Ltd, a pure-play generic injectable pharmaceutical products ......
